THE CONOLIDINE DIARIES

These final results, together with a past report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two support the concept of focusing on ACKR3 as a novel strategy to modulate the opioid technique, which could open up new therapeutic avenues for opioid-similar Problems.Gene expression Evaluation disclosed